Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-12-04
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: This Japanese sub-study of EXTEND ARDS aims to evaluate whether:
1. ΔPes measurements during spontaneous breathing trials (SBT) can predict SBT failure
2. ΔPes measurements post-extubation can predict 48-hour extubation failure
Methods: This prospective observational study will be conducted in Japanese ICUs. Esophageal pressure will be measured using standardized Nutrivent balloons (4mL volume) with Hamilton ventilators. Balloon placement in the lower third of the esophagus will be confirmed by cardiac artifacts and chest X-ray. ΔPes will be calculated as the difference between end-expiratory and peak inspiratory esophageal pressure, excluding esophageal contractions.
Significance: This study addresses a knowledge gap regarding the utility of esophageal pressure monitoring in ARDS patients during mechanical ventilation weaning. Findings may help optimize extubation timing and improve patient outcomes through objective physiological measurements.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inspiratory effort assessment during liberation from mechanical ventilation traditionally relies on respiratory rate monitoring during spontaneous breathing trials (SBT). However, esophageal pressure (Pes) measurement, which provides direct measurement of inspiratory effort, is rarely utilized in clinical practice. This is particularly relevant in ARDS patients, where excessive inspiratory effort can induce pendelluft phenomenon, potentially causing dorsal lung injury in the supine position.
Recent studies have shown that diaphragmatic contraction, maximum inspiratory pressure, ΔPes, and trans-diaphragmatic pressure can predict successful weaning in prolonged mechanical ventilation patients. However, there remains a significant knowledge gap regarding the utility of esophageal pressure measurements in predicting SBT and extubation success specifically in ARDS patients.
2. Study Significance This Japanese sub-study of the EXTEND ARDS trial will investigate whether ΔPes measurements during SBT and post-extubation can predict extubation outcomes in ARDS patients. By incorporating esophageal pressure monitoring, this study aims to provide objective physiological data to improve the prediction of extubation success and optimize the timing of liberation from mechanical ventilation.
3. Study Design and Methods This is a prospective observational sub-study conducted in Japanese ICUs. Esophageal pressure will be measured using Nutrivent balloons with Hamilton C6 or G5 ventilators. The balloon placement will be confirmed by cardiac artifacts and chest X-ray, positioned in the lower third of the esophagus. Balloon volume will be standardized at 4mL, following manufacturer recommendations and GLOBAL WEAN study protocols.
4. Primary Objectives
To evaluate whether:
1. ΔPes measurements during SBT can predict SBT failure
2. ΔPes measurements post-extubation can predict extubation failure within 48 hours
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mechanically ventilated adult ARDS patients
Adult mechanically ventilated patients (≥ 16 years old) with esophageal pressure monitoring, expected to receive invasive mechanical ventilator for more than 48 hours
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who meet the diagnosis of ARDS at the start of invasive mechanical ventilation based on a new global definition of ARDS.
Exclusion Criteria
2. Patients who were transferred to participating hospital more than 2 days after the start of invasive mechanical ventilation
3. Patients with terminal conditions at the start of invasive mechanical ventilation
4. Patients who have expressed their refusal to have their clinical data used in research
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sapporo Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sapporo Medical University
Sapporo, Hokkaido, Japan
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ryuichi Nakayama, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EXTEND_ARDS_J_EP_Study
Identifier Type: -
Identifier Source: org_study_id